-Foundation
April 28th 2007
-Business registry \r\nnumber
913717006613960810
-Reshape, the switchovers of \r\ndomestic funded enterprise to Foreign-invested \r\nenterprise
April 14th 2015
-Location
Heze city, Shandong province, \r\nChina
"We consistently strive for mutual \r\ngrowth and profit all the while offering the best of services."
SDH was founded in 2007 with motives to \r\nsatisfy our customers with the best of services while striving for mutual \r\ngrowth and profit. Committedly, SDH practices being honest and sincere, staying \r\nfully open to our customers' voice, and proactively dealing with change.
In 2015, along with the switch to \r\nforeign companies, SDH began the production of pharmaceutical raw materials and \r\nbegan expanding its business scope to the import and export of cosmetics and \r\nhealth supplements thanks to the cooperation project between South Korea, \r\nMiddle East, and Southeast Asia.
SDH strives to become a company that \r\ncontributes to both society and personal development to both the world and each \r\nindividual staff of the enterprise.
APL laboratory was established in \r\nJinan, Shandong province, China in 2011. It has developed generic \r\npharmaceuticals intermediates and APIs such as Antibiotics, Antihypertensives, \r\nCardiovasculars, Steriods and Hepatitis etc… We having register above APIs in \r\nthe CFDA and successfully tried the mass production until today.
If you want to know more details about \r\nthe laboratory, follow this URL.
APL, sister laboratory of SDH, is \r\nlocated in Jinan City, Shandong Province, China. About 100 synthesizing organic \r\ncompound researchers, 10 Formulations researchers, about 30 QAs, and about 30 \r\nQCs are working for APL. APL is developing generics and register with CFDA in \r\nChina. APL receives CROs and develops new pharmaceuticals.
APL also develops man power through \r\nhiring M.A.+ degree researchers from more than 11 universities in Jinan City \r\nevery year. Accumulated experience and know-how from many years make APL to be \r\ncompetitive and have high level technologies.
-Foundation
April 28th 2007
-Business registry
number
913717006613960810
-Reshape, the switchovers of
domestic funded enterprise to Foreign-invested
enterprise
April 14th 2015
-Location
Heze city, Shandong province,
China
"We consistently strive for mutual
growth and profit all the while offering the best of services."
SDH was founded in 2007 with motives to
satisfy our customers with the best of services while striving for mutual
growth and profit. Committedly, SDH practices being honest and sincere, staying
fully open to our customers' voice, and proactively dealing with change.
In 2015, along with the switch to
foreign companies, SDH began the production of pharmaceutical raw materials and
began expanding its business scope to the import and export of cosmetics and
health supplements thanks to the cooperation project between South Korea,
Middle East, and Southeast Asia.
SDH strives to become a company that
contributes to both society and personal development to both the world and each
individual staff of the enterprise.
APL laboratory was established in
Jinan, Shandong province, China in 2011. It has developed generic
pharmaceuticals intermediates and APIs such as Antibiotics, Antihypertensives,
Cardiovasculars, Steriods and Hepatitis etc… We having register above APIs in
the CFDA and successfully tried the mass production until today.
If you want to know more details about
the laboratory, follow this URL.
APL, sister laboratory of SDH, is
located in Jinan City, Shandong Province, China. About 100 synthesizing organic
compound researchers, 10 Formulations researchers, about 30 QAs, and about 30
QCs are working for APL. APL is developing generics and register with CFDA in
China. APL receives CROs and develops new pharmaceuticals.
APL also develops man power through
hiring M.A.+ degree researchers from more than 11 universities in Jinan City
every year. Accumulated experience and know-how from many years make APL to be
competitive and have high level technologies.